Quetiapine. A collection of useful information for the clinician

2021 ◽  
Vol 14 (2) ◽  
pp. 182-185
Author(s):  
Marcin Siwek
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Antipsychotic Drug ◽  
Medical Practice ◽  
Anxiety Symptoms ◽  
Use Cases ◽  
Generalized Anxiety ◽  
Recurrent Depression ◽  
Proven Efficacy

Quetiapine is an antipsychotic drug with proven efficacy in the treatment of schizophrenia and bipolar disorder as well as recurrent depression and generalized anxiety disorder. There is also evidence of the efficacy of quetiapine in other disorders dominated by affective and/or anxiety symptoms, for which treatment is not registered in Poland. The paper presents information useful in medical practice and presents descriptions of use cases.

Reversal learning in youth with generalized anxiety disorder and bipolar disorder

2014 ◽  
Author(s):  
Grace K. Cushman ◽  
Megan E. Puzia ◽  
Alexandra B. Weissman ◽  
Ezra Wegbreit ◽  
Kerri L. Kim ◽  
...  
Keyword(s):  
Bipolar Disorder ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Reversal Learning ◽  
Generalized Anxiety

Women With Generalized Anxiety Disorder Show Increased Repetitive Negative Thinking During the Luteal Phase of the Menstrual Cycle

2020 ◽  
Vol 8 (6) ◽  
pp. 1037-1045
Author(s):  
Sophie H. Li ◽  
Thomas F. Denson ◽  
Bronwyn M. Graham
Keyword(s):  
Anxiety Disorder ◽  
Menstrual Cycle ◽  
Negative Affect ◽  
Generalized Anxiety Disorder ◽  
Cognitive Processes ◽  
Luteal Phase ◽  
Anxiety Symptoms ◽  
Generalized Anxiety ◽  
Repetitive Negative Thinking ◽  
Negative Thinking

Repetitive negative thinking (RNT) is a transdiagnostic feature of psychiatric disorders. Women report greater RNT than do men, yet the association between uniquely female characteristics, such as fluctuating sex hormones during the menstrual cycle, and RNT has not been established. Here we examined changes in RNT and anxiety symptoms across the menstrual cycle in women with ( n = 40) and without ( n = 41) generalized anxiety disorder (GAD). Women with GAD reported an increase in RNT and negative affect from the follicular phase to the luteal phase; unexpectedly, this was not associated with changes in anxiety symptoms, estradiol, or progesterone. Nonanxious women reported no changes in RNT or anxiety symptoms over the menstrual cycle, but higher within-participants progesterone was associated with reduced RNT and negative affect. These results indicate that uniquely female biological processes may influence core cognitive processes that underlie anxiety disorders, but further investigations to determine the implications for symptom severity are required.

scholarly journals The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice

2012 ◽  
Vol 10 (1) ◽  
pp. 114 ◽  
Author(s):  
Javier García-Campayo ◽  
Enric Zamorano ◽  
Miguel A Ruiz ◽  
María Pérez-Páramo ◽  
Vanessa López-Gómez ◽  
...  
Keyword(s):  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Medical Practice ◽  
The Self ◽  
Spanish Version ◽  
Psychometric Validation ◽  
Generalized Anxiety

P01.63 Venlafaxine er action on generalized anxiety disorder (GAD)-specific anxiety symptoms

2000 ◽  
Vol 15 (S2) ◽  
pp. 337s-337s
Author(s):  
P. Meoni ◽  
D. Hackett ◽  
Y. Brault ◽  
E.O. Salinas
Keyword(s):  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Anxiety Symptoms ◽  
Generalized Anxiety
Sign in / Sign up

Export Citation Format

Share Document